FusionPharm, Inc.
FSPM
$0.0001
$0.000.00%
OTC PK
03/31/2012 | 03/31/2011 | ||||
---|---|---|---|---|---|
Net Income | -596.09% | -126.18% | |||
Total Depreciation and Amortization | -- | -- | |||
Total Amortization of Deferred Charges | -- | -- | |||
Total Other Non-Cash Items | -- | -- | |||
Change in Net Operating Assets | 297.73% | 83.46% | |||
Cash from Operations | -232.41% | -402.33% | |||
Capital Expenditure | -- | -- | |||
Sale of Property, Plant, and Equipment | -- | -- | |||
Cash Acquisitions | -- | -- | |||
Divestitures | -- | -- | |||
Other Investing Activities | -- | -- | |||
Cash from Investing | -- | -- | |||
Total Debt Issued | -- | -- | |||
Total Debt Repaid | -- | -- | |||
Issuance of Common Stock | -52.00% | 509.76% | |||
Repurchase of Common Stock | -- | -- | |||
Issuance of Preferred Stock | -- | -- | |||
Repurchase of Preferred Stock | -- | -- | |||
Total Dividends Paid | -- | -- | |||
Other Financing Activities | -- | -- | |||
Cash from Financing | 48.00% | 509.76% | |||
Foreign Exchange rate Adjustments | -- | -- | |||
Miscellaneous Cash Flow Adjustments | -- | -- | |||
Net Change in Cash | -1,023.53% | 3,500.00% | |||